See up to 3 months of AXGN. The 7-day demo opens the 1M and 3M ranges and puts AXGN on your watchlist.
Start 7-day demoLatest AXGN insider trades
Joseph A. Tyndall - DirectorOpen-market sale$174K- Marc A. Began - OfficerOpen-market sale$3.20M
About Axogen, Inc. (AXGN)
Axogen, Inc. files with the SEC under CIK 0000805928 and is classified as electromedical and electrotherapeutic apparatus. We track it alongside the rest of the Health Care sector.
AXGN Form 4 activity by transaction type, last 90 days
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 4 | 98,503 | $4.66M |
| Option exercise | 4 | 161,706 |
Dollar totals cover purchases and sales only (codes P and S). Grants, option exercises, gifts and tax withholding are counted in shares, because none of them is a trade at a market price.
AXGN insider transactions (Form 4)
7544 Form 4 filings on record, the earliest from Jun 9, 2025, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Joseph A. Tyndall - Director | Open-market sale | Common Stock | 3,500 | $49.70 footnote F2 | $174K | |
| ||||||
| Marc A. Began - Officer | Option exercise | Common Stock | 67,500 | $8.16 | $551K | |
| Marc A. Began - Officer | Open-market sale | Common Stock | 67,500 | $47.35 footnote F2 | $3.20M | |
| Marc A. Began - Officer | Option exercise | Employee Stock Option (right to buy) | 67,500 | $0.00 | - | |
| ||||||
| Amy McBride Wendell - Director | Option exercise | Common Stock | 13,353 | $14.85 | $198K | |
| Amy McBride Wendell - Director | Open-market sale | Common Stock | 13,353 | $48.42 footnote F2 | $647K | |
| Amy McBride Wendell - Director | Option exercise | Employee Stock Option (right to purchase) | 13,353 | $0.00 | - | |
| ||||||
| Kathy Johnson Weiler - Director | Open-market sale | Common Stock | 14,150 | $45.30 footnote F2 | $641K | |
| ||||||
 William P. Mr. Burke - Director | Grant or award | Restricted Stock Units | 4,392 | $0.00 | - | |
| John Johnson - Director | Grant or award | Restricted Stock Units | 4,392 | $0.00 | - | |
 Alan M. Levine - Director | Grant or award | Restricted Stock Units | 4,392 | $0.00 | - | |
| Paul Thomas - Director | Grant or award | Restricted Stock Units | 5,579 | $0.00 | - | |
| Joseph A. Tyndall - Director | Grant or award | Restricted Stock Units | 4,392 | $0.00 | - | |
| Kathy Johnson Weiler - Director | Grant or award | Restricted Stock Units | 4,392 | $0.00 | - | |
| Amy McBride Wendell - Director | Grant or award | Restricted Stock Units | 4,392 | $0.00 | - | |
| Alan M. Levine - Director | Option exercise | Common Stock | 14,150 footnote F1 | $0.00 | - | |
| Alan M. Levine - Director | Option exercise | Restricted Stock Units | 14,150 | $0.00 | - | |
| ||||||
| Kathy Johnson Weiler - Director | Option exercise | Restricted Stock Units | 14,150 | $0.00 | - | |
| Kathy Johnson Weiler - Director | Option exercise | Common Stock | 14,150 footnote F1 | $0.00 | - | |
| ||||||
| Amy McBride Wendell - Director | Option exercise | Common Stock | 14,150 footnote F1 | $0.00 | - | |
| Amy McBride Wendell - Director | Option exercise | Restricted Stock Units | 14,150 | $0.00 | - | |
| ||||||
| Paul Thomas - Director | Option exercise | Restricted Stock Units | 18,867 | $0.00 | - | |
| Paul Thomas - Director | Option exercise | Common Stock | 18,867 footnote F1 | $0.00 | - | |
| ||||||
| Joseph A. Tyndall - Director | Option exercise | Restricted Stock Units | 14,150 | $0.00 | - | |
| Joseph A. Tyndall - Director | Option exercise | Common Stock | 14,150 footnote F1 | $0.00 | - | |
| ||||||
| John Johnson - Director | Option exercise | Common Stock | 14,150 footnote F1 | $0.00 | - | |
| John Johnson - Director | Option exercise | Restricted Stock Units | 14,150 | $0.00 | - | |
| ||||||
| William P. Mr. Burke - Director | Option exercise | Restricted Stock Units | 14,150 | $0.00 | - | |
| William P. Mr. Burke - Director | Option exercise | Common Stock | 14,150 footnote F1 | $0.00 | - | |
| ||||||
| Amy McBride Wendell - Director | Option exercise | Common Stock | 1,647 | $14.85 | $24K | |
| Amy McBride Wendell - Director | Open-market sale | Common Stock | 1,647 | $42.60 footnote F1 | $70K | |
| Amy McBride Wendell - Director | Option exercise | Employee Stock Option (right to purchase) | 1,647 | $0.00 | - | |
| ||||||
| John Johnson - Director | Option exercise | Common Stock | 11,050 | $7.04 | $78K | |
| John Johnson - Director | Open-market sale | Common Stock | 11,050 | $43.26 footnote F1 | $478K | |
| John Johnson - Director | Option exercise | Employee Stock Option (right to purchase) | 11,050 | $0.00 | - | |
| ||||||
| Kathy Johnson Weiler - Director | Option exercise | Common Stock | 16,344 | $6.95 | $114K | |
| Kathy Johnson Weiler - Director | Open-market sale | Common Stock | 16,344 | $44.09 footnote F1 | $721K | |
| Kathy Johnson Weiler - Director | Option exercise | Employee Stock Option (right to purchase) | 16,344 | $0.00 | - | |
| ||||||
| Jens Kemp - Officer | Open-market sale | Common Stock | 4,000 | $43.44 footnote F1 | $174K | |
| ||||||
| Lindsey Marie Hartley - Officer | Option exercise | Employee Stock Option (right to purchase) | 2,500 | $0.00 | - | |
| Lindsey Marie Hartley - Officer | Option exercise | Employee Stock Option (right to purchase) | 2,963 | $0.00 | - | |
| Lindsey Marie Hartley - Officer | Option exercise | Common Stock | 2,500 | $8.20 | $21K | |
| Lindsey Marie Hartley - Officer | Open-market sale | Common Stock | 478 | $43.67 | $21K | |
| Lindsey Marie Hartley - Officer | Option exercise | Common Stock | 2,963 | $8.27 | $25K | |
| Lindsey Marie Hartley - Officer | Open-market sale | Common Stock | 573 | $43.67 | $25K | |
 Doris Quackenbush - Officer | Open-market sale | Common Stock | 3,878 | $43.51 footnote F1 | $169K | |
| ||||||
| Erick Wayne Devinney - Officer | Option exercise | Restricted Stock Units | 6,363 | $0.00 | - | |
| Erick Wayne Devinney - Officer | Option exercise | Restricted Stock Units | 11,575 | $0.00 | - | |
| Erick Wayne Devinney - Officer | Option exercise | Common Stock | 6,363 footnote F1 | $0.00 | - | |
| Erick Wayne Devinney - Officer | Tax withholding / forfeiture | Common Stock | 2,870 footnote F2 | $32.84 | $94K | |
| Erick Wayne Devinney - Officer | Option exercise | Common Stock | 11,575 footnote F1 | $0.00 | - | |
| Erick Wayne Devinney - Officer | Open-market sale | Common Stock | 5,221 footnote F2 | $32.84 | $171K | |
| ||||||
| Lindsey Marie Hartley - Officer | Option exercise | Common Stock | 4,000 footnote F1 | $0.00 | - | |
| Lindsey Marie Hartley - Officer | Tax withholding / forfeiture | Common Stock | 1,574 footnote F2 | $32.84 | $52K | |
| Lindsey Marie Hartley - Officer | Option exercise | Common Stock | 5,000 footnote F1 | $0.00 | - | |
| Lindsey Marie Hartley - Officer | Tax withholding / forfeiture | Common Stock | 1,968 footnote F2 | $32.84 | $65K | |
| Lindsey Marie Hartley - Officer | Option exercise | Restricted Stock Units | 4,000 | $0.00 | - | |
| Lindsey Marie Hartley - Officer | Option exercise | Restricted Stock Units | 5,000 | $0.00 | - | |
| ||||||
| Jens Kemp - Officer | Grant or award | Common Stock | 50,670 footnote F1 | $0.00 | - | |
| Jens Kemp - Officer | Tax withholding / forfeiture | Common Stock | 15,414 footnote F4 | $31.90 | $492K | |
| Jens Kemp - Officer | Tax withholding / forfeiture | Common Stock | 2,952 footnote F5 | $30.65 | $90K | |
| Jens Kemp - Officer | Grant or award | Restricted Stock Units | 23,000 | $0.00 | - | |
| ||||||
| Erick Wayne Devinney - Officer | Grant or award | Common Stock | 33,780 footnote F1 | $0.00 | - | |
| Erick Wayne Devinney - Officer | Tax withholding / forfeiture | Common Stock | 10,702 footnote F2 | $31.90 | $341K | |
| Erick Wayne Devinney - Officer | Tax withholding / forfeiture | Common Stock | 11,276 footnote F3 | $30.65 | $346K | |
| Erick Wayne Devinney - Officer | Grant or award | Restricted Stock Units | 23,000 | $0.00 | - | |
| ||||||
| Marc A. Began - Officer | Grant or award | Common Stock | 33,780 footnote F1 | $0.00 | - | |
| Marc A. Began - Officer | Tax withholding / forfeiture | Common Stock | 8,753 footnote F2 | $31.90 | $279K | |
| Marc A. Began - Officer | Option exercise | Common Stock | 11,250 footnote F3 | $0.00 | - | |
| Marc A. Began - Officer | Tax withholding / forfeiture | Common Stock | 4,427 footnote F4 | $30.65 | $136K | |
| Marc A. Began - Officer | Grant or award | Restricted Stock Units | 23,000 | $0.00 | - | |
| Marc A. Began - Officer | Option exercise | Restricted Stock Units | 11,250 | $0.00 | - | |
| ||||||
| Lindsey Marie Hartley - Officer | Grant or award | Common Stock | 17,453 footnote F1 | $0.00 | - | |
| Lindsey Marie Hartley - Officer | Tax withholding / forfeiture | Common Stock | 6,630 footnote F2 | $31.90 | $211K | |
| Lindsey Marie Hartley - Officer | Grant or award | Restricted Stock Units | 23,000 | $0.00 | - | |
| ||||||
Item 7.01, 9.01
Item 1.01, 7.01, 9.01
Item 1.01, 7.01, 8.01, 9.01
Item 2.02, 7.01, 9.01
Recent AXGN Form 144 notices of proposed sale
3An insider files Form 144 before selling restricted or control stock. It announces a planned sale. If the sale goes ahead, it shows up later on a Form 4.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| JOSEPH A TYNDALL | Director | 3,500 | $175K | View on EDGAR | |
| AMY MCBRIDE-WENDELL | Director | 13,353 | $644K |
AXGN insider trading FAQ
What is the latest insider trade for AXGN?
Axogen, Inc. (AXGN) had 4 insider filings in the last 90 days, with the most recent on 2026-09-04. The full record for AXGN runs to 44 Form 4 filings, the earliest from 2025-06-09. InsiderAlpha adds new Form 4, Form 144 and 8-K filings as they arrive from SEC EDGAR.
How many insiders are buying AXGN stock?
No insider purchases of AXGN were filed in the last 90 days.
How many insiders are selling AXGN stock?
4 insider sales of AXGN were filed in the last 90 days, totaling $4.66M.
Where can I see AXGN SEC filings (Form 4, 10-K, 10-Q, 8-K)?
This page collects AXGN Form 4 insider transactions, Form 144 sale notices and 8-K filings in one place. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
More Health Care companies with insider activity
Recent insider filings
10The EDGAR links open each original Form 4, so you can check any number on this page against the filing it came from.
- - Joseph A. Tyndall view on EDGAR
- - Marc A. Began view on EDGAR
- - Amy McBride Wendell view on EDGAR
- - Kathy Johnson Weiler view on EDGAR
- - William P. Mr. Burke view on EDGAR
- - John Johnson view on EDGAR
- - Alan M. Levine view on EDGAR
- - Paul Thomas view on EDGAR
- - Joseph A. Tyndall view on EDGAR
Related companies with recent insider activity
Learn more
- Insider selling: signal or noise?
- Why most insider sales are routine, and the few patterns worth a second look.
- Form 144 vs Form 4
- A Form 144 announces a planned sale; the Form 4 reports it after it happens.
- Insider activity in Health Care
- Where AXGN's peers are being bought and sold.
- Every recent Form 4
- The market-wide feed, updated as filings arrive from SEC EDGAR.
Follow AXGN with a 7-day demo
- AXGN on your watchlist
- Every AXGN Form 4 filing on record
- Up to 3 months of AXGN price history
- The daily trading plan of ranked insider buys, on a delay, with the plan archive
Start 7-day demoCard required. Your card is never charged for the demo.
